Back to Search
ASHA GUPTA, MD
MD
Allergy & Immunology Physician
NPI: 1669463691IndividualAccepts Medicare
Specialties, Licenses & Credentials
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
1243061(NY)
CMS Specialties
PrimaryALLERGY/IMMUNOLOGY
Education
OTHER
Class of 1971
Research & Publications (20)
The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
PMID 19438818·J Eur Acad Dermatol Venereol·2009
2-rct
Antibodies against G-protein coupled receptors: novel uses in screening and drug development.
PMID 18673273·Comb Chem High Throughput Screen·2008
6-review
Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis.
PMID 18459518·J Drugs Dermatol·2008
1-meta
Role of protein C in renal dysfunction after polymicrobial sepsis.
PMID 17301189·J Am Soc Nephrol·2007
7-preclinical
Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay.
PMID 17714569·Br J Dermatol·2007
8-other
Targeting opioid receptor heterodimers: strategies for screening and drug development.
PMID 16584123·AAPS J·2006
6-review
Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
PMID 16426382·Int J Dermatol·2006
4-observational
Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
PMID 17062029·J Eur Acad Dermatol Venereol·2006
4-observational
The use of receptor-specific antibodies to study G-protein-coupled receptors.
PMID 16878273·Mt Sinai J Med·2006
7-preclinical
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
PMID 16502198·J Cutan Med Surg·2005
4-observational
Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.
PMID 16292454·Skin Therapy Lett·2005
6-review
A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
PMID 15987289·J Eur Acad Dermatol Venereol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 260 RIVERSIDE DR
JOHNSON CITY, NY 13790 - Phone
- (607) 798-7811
Quick Facts
- NPI
- 1669463691
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Publications
- 20
Are you this provider?
Claim Your Profile